All Viruses articles – Page 16
-
NewsBig data study finds RSV vaccine highly effective in protecting older adults
A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV (respiratory syncytial virus) vaccine. VISION Network researchers report that across the board these vaccines were highly effective in older adults, even those with immunocompromising conditions, during the 2023-24 ...
-
NewsCOVID study reveals virus-induced inflammation during pregnancy, redefines vertical transmission
A protein made by SARS-CoV-2 can pass through the placenta and cause serious inflammatory immune responses in the fetus for 66% of pregnancies.
-
NewsMpox vaccine is safe and generates a robust antibody response in adolescents
A clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis of study data.
-
NewsmRNA vaccines for disease outbreaks can be synthesized in less time with new technique
Researchers have developed an innovative synthesis technology capable of producing high purity, fully chemically synthesized mRNA, cutting out the slower enzyme reactions, which could lead to mitigation of future infections at a preliminary stage.
-
NewsNovel app tracks travel-related illnesses
Travelers fall ill surprisingly often during their travels, with health issues occurring on more than one-third of trips, reveals data collected by a novel travel app developed by researchers in cooperation with the World Health Organization (WHO).
-
NewsResearch sheds light on complex evolution of RL11 genes in cytomegalovirus
Using bioinformatics and phylogenetic tools, scientists have discovered RL11 genes are exclusive to cytomegaloviruses in Old World monkeys and great apes, providing insights into virus-host coevolution and immune evasion.
-
NewsHPV vaccination switch to 1-dose gender-neutral approach
Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modelling.
-
NewsSecond round of polio vaccination in the Gaza Strip aims to vaccinate over half a million children
The second round of an emergency polio vaccination campaign is scheduled to start on 14 October 2024 in Gaza, to vaccinate an estimated 591 700 children under ten years of age with a second dose of the novel oral polio vaccine type 2 (nOPV2) vaccine.
-
NewsResearchers identify signs tied to more severe cases of RSV
In a new study, researchers found an increase in NK cells in the airways of children with severe RSV as well as other alterations that suggest these cells may be contributing to disease severity.
-
NewsScientists discover viral trapdoor blocking HIV and herpes
A group of researchers led by Xavier Saelens and Sven Eyckerman at the VIB-UGent Center for Medical Biotechnology discovered how a protein linked to the human immune system wards off HIV-1 and herpes simplex virus-1 by assembling structures in the cell that lure in these viruses and then trap them ...
-
NewsViral messaging can deliver lessons on how infectious diseases spread
A new study explores a hybrid approach to understanding social networks that involves inferring not just social contacts but also the rules that govern how contagion and information spread.
-
NewsMore than 160,000 new virus species discovered by AI
161,979 new species of RNA virus have been discovered using a machine learning tool that researchers believe will vastly improve the mapping of life on Earth and could aid in the identification of many millions more viruses yet to be characterised.
-
NewsIn a warming world, public needs to know more about protections from mosquito-borne illnesses
Very few (15%) among the American public worry that they or their families will contract dengue or West Nile virus over the new three months, according to the latest Annenberg Public Policy Center (APPC) health knowledge survey.
-
NewsTrials show common cold medication significantly improved symptoms in less than two days
Applied Biological Laboratories will present results of a clinical trial which showed Biovanta significantly improved common cold symptoms including sore throat, cough, runny nose, congestion, chills, and sneezing in less than two days.
-
NewsStudy finds persistent infection could explain long COVID in some people
Researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms.
-
NewsStudy probes disparities in hepatitis C care for reproductive-aged women to break cycle of viral transmission
Researchers and clinicians are working to minimize racial and ethnic disparities in hepatitis C testing and treatment for women with opioid use disorder and their children through innovative programs.
-
NewsFirst report of its kind describes HIV reservoir landscape in breast milk
In the first report of its kind, researchers have evaluated the HIV reservoir in the breast milk cells of two women living with HIV (WLWH) who had been on successful long-term treatment.
-
NewsChild Health Day 2024: influenza vaccine protects children from infection and hospitalization
Spain’s influenza vaccination campaign for children aged 6-59 months during the 2023/24 season was effective in preventing acute respiratory infections and hospitalisation, as vaccination was recommended for this age group at the national level for the first time.
-
NewsThe Democratic Republic of the Congo kicks off mpox vaccination
The Democratic Republic of the Congo today kicked off mpox vaccination, adding a vital measure to complement the ongoing outbreak control efforts to halt the spread of the viral disease and save lives. Source: NIAID Colorized transmission electron micrograph of mpox virus particles (teal) cultivated and purified ...
-
NewsWHO launches global strategic plan to fight rising Aedes-borne arboviral diseases
The World Health Organization (WHO) has launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP) to tackle dengue and other Aedes-borne arboviruses.